US Population Eligibility and Estimated Impact of Tirzepatide Treatment on Obesity Prevalence and Cardiovascular Disease Events Nathan D. WongHridhay KarthikeyanWenjun Fan Original Article Open access 08 June 2024
Cardiorenal Syndrome in Right Heart Failure Due to Pulmonary Arterial Hypertension—The Right Ventricle as a Therapeutic Target to Improve Renal Function Kenzo IchimuraAdam GrossMandeep S. Sidhu Invited Review Article 07 June 2024
Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Cancer: A Target Trial Emulation from SEER-Medicare Database Bang TruongLori HornsbyJingjing Qian Original Article Open access 07 June 2024
Enhanced Reendothelialization and Thrombosis Prevention with a New Drug-Eluting Stent Dunpeng CaiAndy C. ChenShi-You Chen Original Article 04 June 2024
Pyroptosis of Vascular Smooth Muscle Cells as a Potential New Target for Preventing Vascular Diseases Chang DiMeng JiRong Qi Review Article 01 June 2024
Transporter Genes and statin-induced Hepatotoxicity Seo-A ChoiJung Sun KimHye Sun Gwak Original Article 29 May 2024
Angiography-based Fractional Flow Reserve for the Prediction of Clinical Outcomes After Drug-coated Balloon or Plain Old Balloon Angioplasty Wei WangXinyi YangXianhe Lin Original Article 28 May 2024
Discharge of Acute Coronary Syndrome Patients on Sub-Optimal Dual Anti-Platelet Therapy: A Single Center Experience Jeffrey B BookerAlexander J NihartJames C Blankenship Original Article 10 May 2024
Rationale and Design of Prospective, Multicenter, Double-Arm Clinical Trial to Investigate the Efficacy of Tofogliflozin on Left Ventricular Diastolic Dysfunction in Patients with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes Mellitus (TOP-HFPEF Trial) Shin ItoYuri NakajimaMasafumi Kitakaze Trial Designs 10 May 2024
LncRNA Gm15834 Aggravates Cardiac Hypertrophy by Interacting with Sam68 and Activating NF-κB Mediated Inflammation Yongsheng LiuMan JiangHongli Sun Original Article 08 May 2024
Left Ventricular Thrombus After Myocardial Infarction: Opinions and Equipoise Shannon ClayJames C. Blankenship Editorial 06 May 2024
miR-210-5p Promotes Pulmonary Hypertension by Blocking ATP2A2 Boxiang WangYidin XuLinbo Yuan Original Article 24 April 2024
Outcomes With Hybrid Catheter-Directed Therapy Compared With Aspiration Thrombectomy for Patients With Intermediate-High Risk Pulmonary Embolism Sylwia Sławek-SzmytAleksander AraszkiewiczMaciej Lesiak Routine Article 02 April 2024
Impairment of Vascular Homeostasis in Acute Heart Failure: Enter the Monocyte? Saifei LiuIndy AJ LawrieJohn D. Horowitz Invited Editorial 23 March 2024 Pages: 405 - 409
Predictors of Plasma Levels of Direct Oral Anticoagulants Among Patients with Atrial Fibrillation in Need of Elective Cardiac Procedures Vincenzo RussoEleonora CaiazzaGerardo Nigro Original Article Open access 20 March 2024
A Comprehensive Overview on Chemotherapy-Induced Cardiotoxicity: Insights into the Underlying Inflammatory and Oxidative Mechanisms András NagyDenise BörzseiRenáta Szabó Review Article Open access 16 March 2024
Surgical Treatment for Type A Aortic Dissection after Endovascular Aortic Repair: A 12-year, Single-Center Study Yuan XueShipan WangHaiyang Li Original Article 15 March 2024
Effectiveness of Vasopressin Against Cardiac Arrest: A Systematic Review of Systematic Reviews Jonathan Ka-Ming HoHon-Lon TamLeona Yuen-Ling Leung Review Article Open access 12 March 2024
The Impacts of Nirmatrelvir–Ritonavir on Myocardial Injury and Long-Term Cardiovascular Outcomes in Hospitalized Patients with COVID-19 amid the Omicron Wave of the Pandemic Jun GuZhi-Hua HanJun-feng Zhang Original Article 11 March 2024
Evinacumab Reduces Triglyceride-Rich Lipoproteins in Patients with Hyperlipidemia: A Post-Hoc Analysis of Three Randomized Clinical Trials Robert S. RosensonDaniel J. RaderRobert Pordy Short Communication Open access 06 March 2024
Exercise Improves Heart Function after Myocardial Infarction: The Merits of AMPK Xiaodi ZhangYi ZhaoDengshen Zhang Review Article Open access 04 March 2024
Aloperine Alleviates Myocardial Injury Induced by Myocardial Ischemia and Reperfusion by Activating the ERK1/2/β-catenin Signaling Pathway Shichao WeiFeng JuZhaoyang Hu Original Article 28 February 2024
An Integrated Network Pharmacology and RNA-seq Approach for Exploring the Protective Effect of Andrographolide in Doxorubicin-Induced Cardiotoxicity Sa LiuJiaqin LiuShengyu Tan Original Article 24 February 2024
Isoimperatorin Inhibits Angiogenesis by Suppressing VEGFR2 Signaling Pathway Yating XuDi XiaMinglu Liang Original Article 16 February 2024
A Practical Approach to the Management of Residual Cardiovascular Risk: United Arab Emirates Expert Consensus Panel on the Evidence for Icosapent Ethyl and Omega-3 Fatty Acids Hani SabbourDeepak L. BhattRonney Shantouf Review Article Open access 16 February 2024
Safety and Effectiveness of Antidysrhythmic Drugs for Pharmacologic Cardioversion of Recent-Onset Atrial Fibrillation: a Systematic Review and Bayesian Network Meta-analysis Ian S. deSouzaPragati ShresthaHenry Thode Jr. Review Article 07 February 2024
Dapagliflozin for Atrial Fibrillation Na LiMihail G. CheluYochai Birnbaum Invited Editorial 06 February 2024 Pages: 1 - 3
The Case Continues to Build: More Data that Intracoronary Thrombolysis Is Safe and Effective in STEMI Spencer NgKevin FriedeGeorge A. Stouffer Editorial 06 February 2024 Pages: 207 - 208
Acute Kidney Injury in Different Anticoagulation Strategies: A Large-Scale Pharmacoepidemiologic Study Using Real-World Data Qiuyu XuGang ChenXuemei Li Original Article 06 February 2024
IL-33 in Atherosclerosis: An Insufficiently Explored and Controversial Research Area Yanyan YeFangyuan ChangYingchun Xu Letter to the Editor 31 January 2024 Pages: 419 - 420
Changes in Heart Rate Variability Parameters Following Radiofrequency Ablation in Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis Mahsa MansourianZahra Teimouri-jervekaniMarjan Mansourian Review Article 30 January 2024
Hyperkalaemia in Cardiological Patients: New Solutions for an Old Problem Maurizio Giuseppe AbrignaniEdoardo Grondaon behalf of the Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) Working Groups on Cardiological Chronicity, Cardiorenal, Metabolic, Heart Failure Review Article 30 January 2024
The Function of Circular RNAs in Myocardial Ischemia–Reperfusion Injury: Underlying Mechanisms and Therapeutic Advancement Kai-Yuan ChenZhou LiuGui-You Liang Review Article 30 January 2024
Open Issues in the Management of Otcagerian Patients with Atrial Fibrillation and Chronic Kidney Disease: Are we Ready for Left Atrial Appendage Occlusion (LAAO) as First-Line Therapy for Thromboembolic Risk Prevention? Francesco CondelloAngelica CersosimoPaolo Pagnotta Editorial 26 January 2024 Pages: 401 - 403
Instent CTO—What Is the Best Treatment Strategy? Mark SahyouniGeorge A. Stouffer Editorial 25 January 2024 Pages: 393 - 394
Comparison Between Drug-Coated Balloon and Stents in Large De Novo Coronary Artery Disease: A Systematic Review and Meta-Analysis of RCT Data Zhiqiang MaKanling LiuZhengyi Li Review Article Open access 25 January 2024
The Toll-like Receptor-2/4 Antagonist, Sparstolonin B, and Inflammatory Diseases: A Literature Mining and Network Analysis Rongyuan YangQingqing LiuQing Liu Original Article 25 January 2024
Numbers Needed to Treat for Preventing Adverse Cardiovascular Outcomes for Sodium-Glucose Cotransporter 2 Inhibitors vs. Dipeptidyl Peptidase 4 Inhibitors: The Hong Kong Diabetes Study Gary TseSharen LeeJiandong Zhou Letter to the Editor 20 January 2024 Pages: 391 - 392
Metabolism Serves as a Bridge Between Cardiomyocytes and Immune Cells in Cardiovascular Diseases Lixiao HangYing ZhangLin Xia Review Article 18 January 2024
Evaluation of Midodrine Utilization in Patients with Cancer and Heart Failure Jorge A. Irizarry-CaroJuhee SongEfstratios Koutroumpakis Original Article 15 January 2024
The Impact of CYP2C19 Genotype on the Platelet Reactivity Index (PRI) among Chronic Coronary Syndromes (CCS) Patients Undergoing Percutaneous Coronary Intervention (PCI): Affectability of Rapid Genetic Testing Mohammed Ahmed AkkaifNur Aizati Athirah DaudBaharudin Ibrahim Original Article 15 January 2024
Association Between the Magnitude of Glycemic Control and Body Weight Loss With GLP-1 Receptor Agonists and Risk of Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-analyses of Randomized Diabetes Cardiovascular Outcomes Trials Daniel A. GomesJoão PresumeJorge Ferreira Original Article 12 January 2024
Comparative Effectiveness and Safety of Direct Oral Anticoagulants in Low Body Weight Patients with Atrial Fibrillation: A Systematic Review and Meta-analysis Mohamed Nabil ElshafeiMuhammad SalemMohammed Danjuma Review Article Open access 02 January 2024
MOTS-c Peptide Attenuated Diabetic Cardiomyopathy in STZ-Induced Type 1 Diabetic Mouse Model Nan WuCaijie ShenPeng Zhong Original Article 23 December 2023
The Infarct-Limiting Effect of Remote Ischemic Conditioning in Rats Is Not Affected by Aspirin M. V. BasalayJames M. DowneyD. M. Yellon Short Communication Open access 20 December 2023
Interplay Between TGF-β Signaling and MicroRNA in Diabetic Cardiomyopathy Jianning QinYao TanShunlin Qu Review Article 20 December 2023
When Less is More: Drug-Coated Balloons Threaten a Paradigm Revolution Bilal AlqamJames C Blankenship Editorial 19 December 2023 Pages: 397 - 399
Influence of a Short Course of Ritonavir Used as Booster in Antiviral Therapies Against SARS-CoV-2 on the Exposure of Atorvastatin and Rosuvastatin Evelyn KrohmerBrit Silja RohrWalter E. Haefeli Original Article Open access 19 December 2023
Oral Anticoagulation for Atrial Fibrillation in Octogenarians Across the Renal Function Spectrum Andreina CarboneRoberta BottinoVincenzo Russo Original Article 18 December 2023
ROS-Activated TRPM2 Channel: Calcium Homeostasis in Cardiovascular/renal System and Speculation in Cardiorenal Syndrome Zihan ChenZaihua ChengXiao Huang Review Article 18 December 2023